Regulation of Mucosal Healing in Inflammatory Bowel Disease

Description

The objective of the current study is to compare non-healing colonic ulcers in patients with inflammatory bowel disease (IBD) with iatrogenic colonic ulcers (biopsy sites) in healthy control patients and patients with rheumatoid or psoriatic arthritis. Patients will be biopsied at baseline and again at a follow-up visit in a "biopsy of the biopsy" approach. These biopsies will be used to reveal patterns about gene expression and mitochondrial function during ulcer healing.

Conditions

Inflammatory Bowel Diseases

Study Overview

Study Details

Study overview

The objective of the current study is to compare non-healing colonic ulcers in patients with inflammatory bowel disease (IBD) with iatrogenic colonic ulcers (biopsy sites) in healthy control patients and patients with rheumatoid or psoriatic arthritis. Patients will be biopsied at baseline and again at a follow-up visit in a "biopsy of the biopsy" approach. These biopsies will be used to reveal patterns about gene expression and mitochondrial function during ulcer healing.

Regulation of Mucosal Healing in Inflammatory Bowel Disease

Regulation of Mucosal Healing in Inflammatory Bowel Disease

Condition
Inflammatory Bowel Diseases
Intervention / Treatment

-

Contacts and Locations

Lexington

University of Kentucky, Lexington, Kentucky, United States, 40536

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Classified in an anesthesia risk group, ASA Class =4
  • * History of bleeding diathesis or coagulopathy
  • * Stroke or transient neurological attack with the last 6 months
  • * Pregnant
  • * Receiving anticoagulants or anti-platelet medications other than low-dose aspirin
  • * Receiving steroid therapy or metformin
  • * HIV positive
  • * Incarceration
  • * History of total proctocolectomy
  • * History of system chemotherapy within 18 months
  • * Uncontrolled intercurrent illness

Ages Eligible for Study

18 Years to 90 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Terrence A Barrett,

Terrence Barrett, MD, PRINCIPAL_INVESTIGATOR, University of Kentucky

Study Record Dates

2025-05-01